{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:54:48Z","timestamp":1785884088253,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003197","name":"Italian Medicines Agency","doi-asserted-by":"publisher","award":["FARM12PW7R\/A6"],"award-info":[{"award-number":["FARM12PW7R\/A6"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ebr.2026.100872","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:11:10Z","timestamp":1778580670000},"page":"100872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative efficacy of agomelatine and escitalopram in people with epilepsy and comorbid major depressive disorder: A double-blind randomized controlled trial"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7005-2805","authenticated-orcid":false,"given":"Mariana","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Avvento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2490-8761","authenticated-orcid":false,"given":"Francesca","family":"Izzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2359-381X","authenticated-orcid":false,"given":"Giovanni","family":"Di Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Teresa","family":"Giallonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Cerulli Irelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Di Bonaventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4505-2600","authenticated-orcid":false,"given":"Andrea","family":"Romigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Biagio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Placidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebr.2026.100872_b0005","series-title":"Neurological disorders: public health challenges","author":"World Health Organization","year":"2006"},{"key":"10.1016\/j.ebr.2026.100872_b0010","doi-asserted-by":"crossref","unstructured":"Neligan A, Hauser WA, Sander JW. The epidemiology of the epilepsies. vol. 107. 1st ed. Elsevier B.V.; 2012, doi: 10.1016\/B978-0-444-52898-8.00006-9.","DOI":"10.1016\/B978-0-444-52898-8.00006-9"},{"key":"10.1016\/j.ebr.2026.100872_b0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","article-title":"Management of psychiatric and neurological comorbidities in epilepsy","volume":"12","author":"Kanner","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ebr.2026.100872_b0020","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/epi.13769","article-title":"Anxiety and depressive disorders in people with epilepsy: a meta\u2010analysis","volume":"58","author":"Scott","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2026.100872_b0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yebeh.2018.04.015","article-title":"Major depressive disorder in epilepsy clinics: a meta-analysis","volume":"84","author":"Kim","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2026.100872_b0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/WCO.0000000000000431","article-title":"Depression in epilepsy","volume":"30","author":"Mula","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ebr.2026.100872_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107703","article-title":"How frequently is anxiety and depression identified and treated in hospital and community samples of adults with epilepsy?","volume":"115","author":"Scott","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2026.100872_b0040","article-title":"Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center","author":"Vacca","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ebr.2026.100872_b0045","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1528-1167.2011.03213.x","article-title":"Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review","volume":"52","author":"Taylor","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2026.100872_b0050","doi-asserted-by":"crossref","first-page":"e932","DOI":"10.1212\/WNL.0000000000201542","article-title":"Directionality of the association between epilepsy and depression: a nationwide register-based cohort study","volume":"100","author":"B\u00f8lling-Ladegaard","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.ebr.2026.100872_b0055","doi-asserted-by":"crossref","unstructured":"Fiest KM, Dykeman J, Patten SB, Wiebe S, Kaplan GG, Maxwell CJ, et al. Depression in epilepsy. Neurology 2013;80:590 LP \u2013 599, doi: 10.1212\/WNL.0b013e31827b1ae0.","DOI":"10.1212\/WNL.0b013e31827b1ae0"},{"key":"10.1016\/j.ebr.2026.100872_b0060","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1212\/CPJ.0000000000000874","article-title":"Psychiatric comorbidities in people with epilepsy","volume":"11","author":"Mula","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.ebr.2026.100872_b0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.yebeh.2017.02.032","article-title":"The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: is it worth investigating?","volume":"70","author":"Ribot","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2026.100872_b0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/epi.12100","article-title":"The treatment of depressive disorders in epilepsy: what all neurologists should know","volume":"54","author":"Kanner","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2026.100872_b0075","first-page":"CD010682","article-title":"Antidepressants for people with epilepsy and depression","volume":"16","author":"Maguire","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ebr.2026.100872_b0080","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrd3140","article-title":"Agomelatine, the first melatonergic antidepressant: discovery, characterization and development","volume":"9","author":"De Bodinat","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ebr.2026.100872_b0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2018.09.014","article-title":"Effects of agomelatine on electrocorticogram activity on penicillin-induced seizure model of rats","volume":"690","author":"Ethemoglu","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.ebr.2026.100872_b0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/hup.1112","article-title":"Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients","volume":"25","author":"Quera-Salva","year":"2010","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.ebr.2026.100872_b0095","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1111\/bph.12720","article-title":"Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties","volume":"171","author":"Guardiola-Lemaitre","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebr.2026.100872_b0100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1556\/019.70.2019.38","article-title":"The reducing effect of agomelatine on pentylenetetrazol-induced convulsions","volume":"70","author":"Demirel","year":"2019","journal-title":"Biol Futur"},{"key":"10.1016\/j.ebr.2026.100872_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.109641","article-title":"Efficacy and safety of agomelatine in epilepsy patients with sleep and mood disorders: an observational, retrospective cohort study","volume":"152","author":"Jiang","year":"2024","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2026.100872_b0110","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 2013. https:\/\/doi.org\/10.1176\/appi.books.9780890425596.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.ebr.2026.100872_b0115","article-title":"Beck depression inventory\u2013II","author":"Beck","year":"1996","journal-title":"Psychol Assess"},{"key":"10.1016\/j.ebr.2026.100872_b0120","series-title":"The Italian versions of the Beck Anxiety Inventory and the Beck Depression Inventory-II: Psychometric properties and discriminant power. Leading-edge psychological tests and testing research","first-page":"27","author":"Sica","year":"2007"},{"key":"10.1016\/j.ebr.2026.100872_b0125","doi-asserted-by":"crossref","first-page":"107073","DOI":"10.1016\/j.yebeh.2020.107073","article-title":"Depressive symptoms and difficulties in emotion regulation in adult patients with epilepsy: association with quality of life and stigma","volume":"107","author":"Tombini","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2026.100872_b0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ebr.2026.100872_b0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0447.1982.tb00911.x","article-title":"The Hamilton depression rating scale in normals and depressives","volume":"66","author":"Fava","year":"1982","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.ebr.2026.100872_b0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1528-1157.1998.tb01278.x","article-title":"Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory","volume":"39","author":"Cramer","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2026.100872_b0145","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.seizure.2005.07.008","article-title":"Validity and reliability of the Italian version of the quality-of-life in epilepsy inventory (QOLIE-31)","volume":"14","author":"Beghi","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.ebr.2026.100872_b0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.ebr.2026.100872_b0155","doi-asserted-by":"crossref","unstructured":"Curcio G, Tempesta D, Scarlata S, Marzano C, Moroni F, Maria P. Validity of the Italian Version of the Pittsburgh Sleep Quality Index (PSQI) 2013:511-9. doi: 10.1007\/s10072-012-1085-y.","DOI":"10.1007\/s10072-012-1085-y"},{"key":"10.1016\/j.ebr.2026.100872_b0160","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.ebr.2026.100872_b0165","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s100720300004","article-title":"Italian version of the Epworth sleepiness scale: external validity","volume":"23","author":"Vignatelli","year":"2003","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ebr.2026.100872_b0170","first-page":"378","article-title":"The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment","volume":"36","author":"Carlesimo","year":"1996","journal-title":"Eur Neurol"},{"key":"10.1016\/j.ebr.2026.100872_b0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-0043-117962","article-title":"Epileptic seizures under antidepressive drug treatment: systematic review","volume":"51","author":"Steinert","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ebr.2026.100872_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109352","article-title":"VE-MMODE - a randomized controlled trial of Venlafaxine versus Escitalopram for treatment of mild to moderate depression in persons with epilepsy","volume":"145","author":"Bhatele","year":"2023","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2026.100872_b0185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mehy.2013.11.017","article-title":"Therapeutic potential of agomelatine in epilepsy and epileptic complications","volume":"82","author":"Vimala","year":"2014","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ebr.2026.100872_b0190","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1111\/epi.18080","article-title":"Fluoxetine accelerates epileptogenesis and magnifies disease severity in a rat model of acquired epilepsy","volume":"65","author":"Dezsi","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2026.100872_b0195","doi-asserted-by":"crossref","first-page":"zsaa092","DOI":"10.1093\/sleep\/zsaa092","article-title":"Effects of agomelatine and mirtazapine on sleep disturbances in major depressive disorder: evidence from polysomnographic and resting-state functional connectivity analyses","volume":"43","author":"Mi","year":"2020","journal-title":"Sleep"},{"key":"10.1016\/j.ebr.2026.100872_b0200","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.4088\/JCP.09m05347blu","article-title":"Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline","volume":"71","author":"Kasper","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ebr.2026.100872_b0205","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1017\/S1461145713000679","article-title":"Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial","volume":"16","author":"Corruble","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.ebr.2026.100872_b0210","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/YIC.0b013e328349b117","article-title":"Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients","volume":"26","author":"Quera-Salva","year":"2011","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.ebr.2026.100872_b0215","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3892\/etm.2020.9275","article-title":"Comparison of clinical efficacy of oxcarbazepine and lamotrigine combined with escitalopram, and impact on prognostic quality of life in treating patients with epilepsy and depressive disorder","volume":"20","author":"Zhang","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ebr.2026.100872_b0220","first-page":"2441","article-title":"Effect of escitalopram on cognitive function in depression: a mismatch negativity potentials study","volume":"6","author":"Zhou","year":"2011","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.ebr.2026.100872_b0225","first-page":"43","article-title":"Clinical experience with agomelatine for the treatment of depression in elderly patients in outpatient practice","volume":"114","author":"Gavrilova","year":"2014","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"10.1016\/j.ebr.2026.100872_b0230","series-title":"Treatment of depression with cognitive impairment","first-page":"77","volume":"118","author":"Medvedev","year":"2018"},{"key":"10.1016\/j.ebr.2026.100872_b0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/2045125316646064","article-title":"Insomnia and dementia: is agomelatine treatment helpful? Case report and review of the literature","volume":"6","author":"Alt\u0131nyazar","year":"2016","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.ebr.2026.100872_b0240","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2165\/11534420-000000000-00000","article-title":"Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness","volume":"24","author":"Kennedy","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ebr.2026.100872_b0245","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jad.2016.03.048","article-title":"Early effect on general interest, and short-term antidepressant efficacy and safety of agomelatine (25\u201350mg\/day) and escitalopram (10\u201320mg\/day) in outpatients with Major Depressive Disorder. a 12-week randomised double-blind comparative study","volume":"199","author":"Udristoiu","year":"2016","journal-title":"J Affect Disord"}],"container-title":["Epilepsy & Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986426000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986426000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:36:17Z","timestamp":1785882977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589986426000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":49,"alternative-id":["S2589986426000262"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2026.100872","relation":{},"ISSN":["2589-9864"],"issn-type":[{"value":"2589-9864","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy of agomelatine and escitalopram in people with epilepsy and comorbid major depressive disorder: A double-blind randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2026.100872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100872"}}